CD47 and cancer: From the perspective of the “Cancer Cell Fusion” theory, a possible explanation for the favourable outcomes of CD47-SIRPα blockade is that CD47 on cancer cells may act as a trigger for macrophage-cancer cell fusion, mediated by the SIRPα marker on myeloid cells.